Faulty hip implants: 171 patients received compensation from J&J so far, Health Ministry confirms
On May 30 last year, the Delhi High Court ordered the US pharma major to pay the sum of Rs 25 lakhs to each verified claimant.
Around 171 patients have received compensation so far for faulty hip implants from Johnson and Johnson (J&J), the Ministry of Health Affairs informed Parliament on Tuesday.
Replying to a query in Rajya Sabha, Minister of State for Health Affairs Ashwini Kumar Choubey said the Delhi High Court , on May 30 last year, ordered that the US pharma major pay the sum of Rs 25 lakh to each verified claimant, without prejudice to the rights of the claimants.
"Based on the court order, a list of verified claimants along with supporting documents has been provided to M/s Johnson and Johnson for complying with the court's order. As per records, 171 patients have received compensation," Choubey said.
The government had constituted a committee to examine the issues relating to faulty acetabular surface replacement (ASR) Hip Implants. The committee, after detailed examination of the issue, submitted its report to the government, which accepted the recommendations with some modifications.
Based on the accepted recommendations, the government constituted a Central Expert Committee under the Chairmanship of Dr R K Arya, Director, Sports Injury Centre, Safdarjung Hospital, New Delhi, inter-alia to determine the quantum of compensation.
"A formula for determining compensation for the affected patients has been formulated and placed in public domain. The affected patients can approach either the Central Expert Committee or state level committees constituted by the state governments as per their convenience.
"M/s Johnson & Johnson Pvt. Ltd. was asked to comply with the recommendations of the committee and to pay the compensation as per the formula approved by the government in the interest of the patients. However, M/s Johnson & Johnson Pvt. Ltd. challenged the expert committee report on payment of compensation before the Honourable High Court of Delhi," he said.
J&J's ASR (Articular Surface Replacement) XL Acetabular System and ASR Hip Resurfacing System had to be withdrawn globally after complications required many patients to undergo revision surgery.
When the prosthetic ball and socket of the system rub against each other, it causes wear. If the implant is metal on metal, this can release metallic debris into the bloodstream. Which can lead to complications, sometimes requiring revision surgery. Of the 93,000 patients implanted with ASR worldwide, many experienced serious adverse reactions, some requiring revision surgery to replace the ASR implant with another kind. Because of this, the company had to the product on August 24, 2010.
In India, the company got the licence to import the device in 2006. By the time it was recalled worldwide, an estimated 4,700 ASR implants had already been done in the country.
In the 2018 Netflix documentary 'The Bleeding Edge', the crisis triggered by these faulty impants were captured in harrowing details. Have a look at the trailer here: